[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351546-105":59,"doc-detail-351546-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-glycolysis-lactylation-axis-a-metabolic-epigenetic-driver-of-immunosuppression-and-therapy-resistance-in-cancer-review","The glycolysis-lactylation axis - a metabolic-epigenetic driver of immunosuppression and therapy resistance in cancer - Review","","The immunosuppressive tumor microenvironment (TME) limits cancer immunotherapy, and metabolic reprogramming—especially aerobic glycolysis—drives lactate accumulation. Lactate-derived lysine lactylation (Kla) links metabolic activity to immune regulation and tumor resilience, shaping a multi-layered immunosuppressive program and broad therapy resistance. This review synthesizes mechanisms including M2 macrophage polarization, Treg enhancement, CD8+ exhaustion, lactylation-driven DNA repair and stemness, and PD-L1 stabilization, then evaluates emerging therapeutic targeting strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-glycolysis-lactylation-axis-a-metabolic-epigenetic-driver-of-immunosuppression-and-therapy-resistance-in-cancer-review/351546/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-glycolysis-lactylation-axis-a-metabolic-epigenetic-driver-of-immunosuppression-and-therapy-resistance-in-cancer-review/351546.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does aerobic glycolysis contribute to immunosuppression in the tumor microenvironment?","Question",{"text":113,"@type":114},"Aerobic glycolysis (Warburg effect) increases lactate production and secretion, acidifying the TME and promoting immunomodulatory effects that hinder antitumor immunity.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is lysine lactylation (Kla) and why is it important?",{"text":118,"@type":114},"Kla is a reversible post-translational modification derived from lactate that occurs on histone and non-histone proteins, directly coupling metabolic flux to epigenetic reprogramming and altered protein function.",{"name":120,"@type":111,"acceptedAnswer":121},"Which mechanisms link the glycolysis-lactylation axis to immunotherapy resistance?",{"text":122,"@type":114},"The review highlights immune suppression via M2 macrophage polarization, enhanced Treg function, and CD8+ T cell exhaustion, alongside tumor-intrinsic resistance through lactylation-mediated DNA repair and stemness, and undermining immunotherapy by stabilizing PD-L1.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351546,1790142401,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Review  \nPUBLISHED 14 April 2026  \nDOI 10.3389/fimmu.2026.1772701  \nOPEN ACCESS  \nEDITED BY  \nAmol Suryawanshi,  \nNorth Carolina State University, United States  \nREVIEWED BY  \nFerrin Antony,  \nCalico Life Sciences LLC, United States Someshwar Jha,  \nNational Institute of Immunology (NII), India  \n*CORRESPONDENCE  \nHai Zeng  \n[zenghai0716@163.com](zenghai0716@163.com)[ ](zenghai0716@163.com)Jun Cai  \n [caijun20070511@163.com](caijun20070511@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 21 December 2025  \nREVISED 18 March 2026  \nACCEPTED 23 March 2026  \nPUBLISHED 14 April 2026  \nCITATION  \nTan S, Zhang W, Ding Y, Liu J, Zhu M, Luo X, Cai J and Zeng H (2026) The glycolysis-lactylation axis: a metabolicepigenetic driver of immunosuppression and therapy resistance in cancer.  \nFront. Immunol. 17:1772701 .  \ndoi: 10.3389/fimmu.2026.1772701  \nCOPYRIGHT  \n© 2026 Tan, Zhang, Ding, Liu, Zhu, Luo, Cai and Zeng. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe glycolysis-lactylation axis: a metabolic-epigenetic driver of immunosuppression and therapy resistance in cancer  \nSimin Tan †, Weijia Zhang †, Yuqing Ding, Jinlin Liu, Min Zhu, Xuefeng Luo, Jun Cai* and Hai Zeng*  \nDepartment of Oncology, The First Afﬁliated Hospital of Yangtze University, Jingzhou, Hubei, China  \nBackground: The immunosuppressive tumor microenvironment (TME) is a major barrier to the efﬁcacy of cancer immunotherapy. Tumor metabolic reprogramming, particularly aerobic glycolysis (the Warburg effect), drives lactate accumulation in the TIME. Beyond fueling tumor growth, lactatederived lysine lactylation (Kla) has emerged as a pivotal epigenetic and posttranslational modiﬁer, directly coupling metabolic activity to the regulation of immune cell function and tumor cell resilience.  \nMain body: This review synthesizes current evidence to delineate how the glycolysis-lactylation axis orchestrates a multi-faceted immunosuppressive program and confers broad therapy resistance. We detail its mechanisms in: (1) Inhibiting antitumor immunity by driving M2 macrophage polarization, enhancing regulatory T cell (Treg) function, and promoting CD8+ T cell exhaustion; (2) Enhancing intrinsic tumor cell resistance through lactylation-mediated DNA damage repair and stemness maintenance; and (3) Directly undermining immunotherapy, notably by stabilizing programmed cell death 1 ligand 1 (PD-L1) . We critically evaluate emerging therapeutic strategies that target this axis, including inhibitors of glycolytic enzymes, lactate transporters (MCTs), and lactylation writers/ erasers, and their potential to synergize with established immunotherapies. Conclusions: Targeting the lactate-lactylation signaling hub represents a promising metabolic-epigenetic strategy to dismantle tumor-driven immunosuppression and overcome therapeutic resistance, particularly resistance to immunotherapy. Although a substantial body of preclinical evidence, ranging from cancer cell line models to patient-derived xenografts, supporting the potential of targeting this axis, its clinical translation remains hindered by a gap in the evidence hierarchy, necessitating further validation through prospective clinical trials.  \nKEYWORDS  \nglycolytic reprogramming, immune evasion, immunotherapy resistance, lactylation, metabolic-epigenetic, tumor microenvironment (TME)  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nMetabolic reprogramming is an established hallmark of cancer, with the abnormal activation of aerobic glycolysis, the Warburg effect being pa","cbCaiguX04EelfB9","https://ap.wps.com/l/cbCaiguX04EelfB9","pdf",1595909,17,"English","# Introduction\n## Metabolic reprogramming and lactate in the TME\n## Lactate-derived lysine lactylation (Kla)\n## Immunotherapy resistance and the glycolysis-lactylation axis","[{\"question\":\"How does aerobic glycolysis contribute to immunosuppression in the tumor microenvironment?\",\"answer\":\"Aerobic glycolysis (Warburg effect) increases lactate production and secretion, acidifying the TME and promoting immunomodulatory effects that hinder antitumor immunity.\"},{\"question\":\"What is lysine lactylation (Kla) and why is it important?\",\"answer\":\"Kla is a reversible post-translational modification derived from lactate that occurs on histone and non-histone proteins, directly coupling metabolic flux to epigenetic reprogramming and altered protein function.\"},{\"question\":\"Which mechanisms link the glycolysis-lactylation axis to immunotherapy resistance?\",\"answer\":\"The review highlights immune suppression via M2 macrophage polarization, enhanced Treg function, and CD8+ T cell exhaustion, alongside tumor-intrinsic resistance through lactylation-mediated DNA repair and stemness, and undermining immunotherapy by stabilizing PD-L1.\"}]","The glycolysis-lactylation axis - a metabolic-epigenetic driver of immunosuppression and therapy resistance in cancer - Review | PDF",1790094661,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5fbe0979c8ca8fdbcbf7308547163cd.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6adaacf712f9e2cf4aae6e6bbd59d9f.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d04e609a8bc84e11e227c76ac625fb2.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3a5e83a12dba0199a730c2196e5c50c.webp",980,1385]